Intomics is a privately owned biotechnology company spun out from the Center for Biological Sequence Analysis, Technical University of Denmark in 2008 to provide state-of-the-art solutions within biological data analysis to proprietary data for the pharmaceutical and biotechnology industry. Intomics is based in Lyngby, Denmark
Intomics help companies in the life science sector optimize their use of biomedical data in Research and Development projects. As data generation becomes cheaper and cheaper, discovering the underlying biology from high-throughput data becomes key. Based on our proprietary tools, databases, and unique knowledge we provide customized analyses and solutions that meet the need of the individual customer in every project, hereby increasing success rate at reduced expense.
We have leading expertise in biomedical analysis and mining, bioinformatics, and systems biology, and have strong experience with a broad range of data types, including transcriptomics, proteomics, protein-protein interactions, free text resources, genome-wide association studies. Our services are relevant in various stages of drug research, and have with great success been used in areas such as biomarker discovery and optimization, target identification, drug discovery, patient stratification and translational research.
DK-2800 Kgs. Lyngby
Phone: +45 8880 7979